These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32795093)

  • 21. Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression.
    Hatami N; Ahi S; Sadeghinikoo A; Foroughian M; Javdani F; Kalani N; Fereydoni M; Keshavarz P; Hosseini A
    Endocrine; 2020 Jun; 68(3):479-484. PubMed ID: 32542429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE2 Expression and Risk Factors for COVID-19 Severity in Patients with Advanced Age.
    Tavares CAM; Avelino-Silva TJ; Benard G; Cardozo FAM; Fernandes JR; Girardi ACC; Jacob Filho W
    Arq Bras Cardiol; 2020 Oct; 115(4):701-707. PubMed ID: 33111872
    [No Abstract]   [Full Text] [Related]  

  • 23. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.
    Zhao Y; Zhao Z; Wang Y; Zhou Y; Ma Y; Zuo W
    Am J Respir Crit Care Med; 2020 Sep; 202(5):756-759. PubMed ID: 32663409
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
    Öztürk AB; Çağlayan B
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
    Yamamoto N; Ariumi Y; Nishida N; Yamamoto R; Bauer G; Gojobori T; Shimotohno K; Mizokami M
    Gene; 2020 Oct; 758():144944. PubMed ID: 32628976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why does Japan have so few cases of COVID-19?
    Iwasaki A; Grubaugh ND
    EMBO Mol Med; 2020 May; 12(5):e12481. PubMed ID: 32275804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations.
    Srivastava A; Pandey RK; Singh PP; Kumar P; Rasalkar AA; Tamang R; van Driem G; Shrivastava P; Chaubey G
    PLoS One; 2020; 15(9):e0238255. PubMed ID: 32936832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.
    Yuan J; Fan D; Xue Z; Qu J; Su J
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):13. PubMed ID: 33049061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
    Chai P; Yu J; Ge S; Jia R; Fan X
    J Hematol Oncol; 2020 May; 13(1):43. PubMed ID: 32366279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular molecular mechanisms of disease with COVID-19.
    Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
    J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
    [No Abstract]   [Full Text] [Related]  

  • 31. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
    Silhol F; Sarlon G; Deharo JC; Vaïsse B
    Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
    [No Abstract]   [Full Text] [Related]  

  • 32. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
    Guo X; Chen Z; Xia Y; Lin W; Li H
    J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.
    Du M; Cai G; Chen F; Christiani DC; Zhang Z; Wang M
    Gastroenterology; 2020 Jun; 158(8):2298-2301.e7. PubMed ID: 32234303
    [No Abstract]   [Full Text] [Related]  

  • 34. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
    Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F
    Clin Chem Lab Med; 2020 Aug; 58(9):1415-1422. PubMed ID: 32598305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-derived attributes contributing to SARS-CoV-2 mortality.
    Chanana N; Palmo T; Sharma K; Kumar R; Graham BB; Pasha Q
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E562-E567. PubMed ID: 32726128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
    Diaz JH
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19.
    Li G; He X; Zhang L; Ran Q; Wang J; Xiong A; Wu D; Chen F; Sun J; Chang C
    J Autoimmun; 2020 Aug; 112():102463. PubMed ID: 32303424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 and the next generations: which impact on reproductive tissues?
    Zupin L; Pascolo L; Zito G; Ricci G; Crovella S
    J Assist Reprod Genet; 2020 Oct; 37(10):2399-2403. PubMed ID: 32783136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.